Johnson & Johnson in talks to buy Dutch biotech firm Crucell for $2.29 billion

Johnson & Johnson plans to buy Crucell for $2.3B)

Dutch group pushing for right to suicide for people older than 70 gains support

Dutch group endorses right to suicide for elderly

Johnson & Johnson takes 18 percent stake in Crucell for euro301.8 million

Johnson & Johnson buys 18 percent stake in Crucell

AMSTERDAM — U.S. health care products maker Johnson & Johnson Inc. has bought an 18 percent stake in biotechnology company Crucell NV for €301.8 million ($440 million), the Dutch company said in a statement Monday.